(Washington, DC) — The National Coalition for Osteoporosis and Related Bone Diseases applauds Rep. Berkley (D-NV), Rep. Burgess (R-TX) and the more than 60 Members of Congress who have joined together to introduce the Bone Health Promotion and Research Act of 2009. "We are pleased to have bipartisan support for this timely legislation which will educate Americans about achieving better bone health as well as help people who suffer from debilitating bone diseases, fulfilling the call to action from the Surgeon General's 2004 Report on, Bone Health and Osteoporosis," stated Ethel S. Siris, M.D., Madeline C. Stabile Professor of Clinical Medicine; Director, Toni Stabile Osteoporosis Center; Columbia University Medical Center, New York, NY.
On Thursday, May 21st the U.S. House of Representatives passed a resolution supporting the goals and ideals of National Osteoporosis Awareness and Prevention Month, which takes place in May. The bill, H. Res. 369, was introduced by Congresswoman Shelley Berkley of Nevada and helps bring attention to a major public health threat for an estimated 44 million Americans, osteoporosis.
National Osteoporosis Awareness and Prevention Month is celebrated in May with educational and awareness campaigns all over the country. In May, NOF and others are spreading the word that osteoporosis is beatable and treatable. To recognize National Osteoporosis Awareness and Prevention Month, NOF has developed a Bone Tool Kit. The kit is a great resource for basic, easy-to-read information on bone health and osteoporosis, as well as specific information for diverse target audiences. During the month of May, you can take action to protect your bone health and prevent osteoporosis!
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.